Bionow | News

Report: Preparation, Characterisation and in vitro Assessment of siRNA-loaded Li...

Oct 30th 2024

Medicines Discovery Catapult is developing new ways to characterise the physical properties of nanoparticles using single-molecule localisation microscopy.

£1.3M to develop new inhaled drug delivery platforms to treat viral and bacteri...

Mar 8th 2022

The University of Liverpool in partnership with the Liverpool School of Tropical Medicine have joined forces on a £1.3million research project to develop new inhaled drug delivery platforms...

Aptamer Group and WuXi AppTec Research Service Division collaborate to identify ...

Jul 22nd 2021

Aptamer Group Limited, the developer of Optimer™ therapeutics and diagnostics, and WuXi AppTec Research Service Division, an integrated chemistry and biology research platform, today annou...

Aptamer Group and PinotBio collaborate to develop new therapeutic drug conjugate...

Jun 2nd 2021

Aptamer Group Limited, the developer of Optimer™ Therapeutics, and PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, today announces that they have en...

Choose YSDS to take care of your time and temperature sensitive shipments

May 24th 2021

Your Special Delivery Service (YSDS) is an international logistics company specializing in high-quality logistics consulting and seamless global shipping solutions mainly in the field of Lif...

UK Innovators Target Nanoparticles at Inoperable Cancers

Dec 21st 2020

Active Needle Technology, Xerion Healthcare and Medicines Discovery Catapult win funding to begin ground-breaking project

N4 Pharma Covid-19 Project Update

Apr 16th 2020

N4 Pharma Plc , the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide an update on the timing and work t...

University collaboration offers ‘real benefits for patients’ in Yorkshire

Sep 6th 2019

A new applied health research centre brings together experts from the Universities of Leeds, University of Bradford and the local NHS

Aptamer Group Secures $2.2m Series A Investment

Jul 31st 2018

Aptamer Group Ltd, has recently closed its Series A investment round; attracting international interest and securing $2.2m of funding from overseas investors, to support its pioneering aptam...

Get Ahead in MedTech

Jan 30th 2018

Get ahead in MedTech is a tailored programme created and delivered by Bionow to enable medical technology SMEs to commercialise health-related products and services and fully realise their p...

News